These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26351210)

  • 41. Synergistic interaction of hyperthermia and Gemcitabine in lung cancer.
    Vertrees RA; Das GC; Popov VL; Coscio AM; Goodwin TJ; Logrono R; Zwischenberger JB; Boor PJ
    Cancer Biol Ther; 2005 Oct; 4(10):1144-53. PubMed ID: 16138007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
    Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
    J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy.
    Ye X; Xie G; Liu Z; Tang J; Cui M; Wang C; Guo C; Tang J
    Med Sci Monit; 2020 Sep; 26():e922703. PubMed ID: 32946432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
    Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.
    Ikeda R; Vermeulen LC; Lau E; Jiang Z; Sachidanandam K; Yamada K; Kolesar JM
    Int J Oncol; 2011 Feb; 38(2):513-9. PubMed ID: 21152861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
    Vendetti FP; Lau A; Schamus S; Conrads TP; O'Connor MJ; Bakkenist CJ
    Oncotarget; 2015 Dec; 6(42):44289-305. PubMed ID: 26517239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bazedoxifene Inhibits Cell Viability, Colony-Forming Activity, and Cell Migration in Human Non-Small Cell Lung Cancer Cells and Improves the Treatment Efficacy of Paclitaxel and Gemcitabine.
    Huang Y; Lin J; Fu X; Li L; Fu S
    Clin Respir J; 2024 Aug; 18(8):e13822. PubMed ID: 39152779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.
    Liu F; Shang Y; Chen SZ
    Acta Pharmacol Sin; 2014 May; 35(5):645-52. PubMed ID: 24727941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.
    Giovannetti E; Mey V; Nannizzi S; Pasqualetti G; Marini L; Del Tacca M; Danesi R
    Mol Pharmacol; 2005 Jul; 68(1):110-8. PubMed ID: 15795320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478.
    Luk PP; Galettis P; Links M
    Lung Cancer; 2011 Sep; 73(3):274-82. PubMed ID: 21277645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression.
    Kurdow R; Schniewind B; Zoefelt S; Boenicke L; Boehle AS; Dohrmann P; Kalthoff H
    Langenbecks Arch Surg; 2005 Jun; 390(3):243-8. PubMed ID: 15726400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells.
    Nakajima Y; Takagi H; Kakizaki S; Horiguchi N; Sato K; Sunaga N; Mori M
    Anticancer Res; 2012 Dec; 32(12):5251-62. PubMed ID: 23225424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
    Higgins B; Kolinsky K; Smith M; Beck G; Rashed M; Adames V; Linn M; Wheeldon E; Gand L; Birnboeck H; Hoffmann G
    Anticancer Drugs; 2004 Jun; 15(5):503-12. PubMed ID: 15166626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells.
    Hu C; Du W
    Aging (Albany NY); 2020 Nov; 12(24):25767-25777. PubMed ID: 33232271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
    Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ
    Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aloe-emodin induces autophagy and apoptotic cell death in non-small cell lung cancer cells via Akt/mTOR and MAPK signaling.
    Shen F; Ge C; Yuan P
    Eur J Pharmacol; 2020 Nov; 886():173550. PubMed ID: 32926915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
    Okita R; Wolf D; Yasuda K; Maeda A; Yukawa T; Saisho S; Shimizu K; Yamaguchi Y; Oka M; Nakayama E; Lundqvist A; Kiessling R; Seliger B; Nakata M
    PLoS One; 2015; 10(10):e0139809. PubMed ID: 26439264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
    Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
    Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.